Giuseppe Orlando to Young Adult
This is a "connection" page, showing publications Giuseppe Orlando has written about Young Adult.
Connection Strength
0.219
-
Senger RS, Sullivan M, Gouldin A, Lundgren S, Merrifield K, Steen C, Baker E, Vu T, Agnor B, Martinez G, Coogan H, Carswell W, Kavuru V, Karageorge L, Dev D, Du P, Sklar A, Pirkle J, Guelich S, Orlando G, Robertson JL. Spectral characteristics of urine from patients with end-stage kidney disease analyzed using Raman Chemometric Urinalysis (Rametrix). PLoS One. 2020; 15(1):e0227281.
Score: 0.026
-
Senger RS, Kavuru V, Sullivan M, Gouldin A, Lundgren S, Merrifield K, Steen C, Baker E, Vu T, Agnor B, Martinez G, Coogan H, Carswell W, Karageorge L, Dev D, Du P, Sklar A, Orlando G, Pirkle J, Robertson JL. Spectral characteristics of urine specimens from healthy human volunteers analyzed using Raman chemometric urinalysis (Rametrix). PLoS One. 2019; 14(9):e0222115.
Score: 0.026
-
Rogers J, Farney AC, Orlando G, Harriman D, Reeves-Daniel A, Jay CL, Doares W, Kaczmorski S, Gautreaux MD, Stratta RJ. Dual Kidney Transplantation from Donors at the Extremes of Age. J Am Coll Surg. 2019 04; 228(4):690-705.
Score: 0.025
-
Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation. 2016 Jan; 100(1):194-202.
Score: 0.020
-
Ortona E, Colasanti T, Derme M, Iannini I, Vomero M, Sorice M, D'Alessandro F, Costa AN, Malorni W, Orlando G, Framarino-dei-Malatesta M. Serum Antiphospholipid Antibodies in Transplanted Patients: Potential Follow-up Markers to Assess Pregnancy Risk? Transplantation. 2015 Sep; 99(9):e152-4.
Score: 0.020
-
Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW, Langefeld CD, Hicks PJ, Ma L, Freedman BI. Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Kidney Int. 2015 Sep; 88(3):584-92.
Score: 0.019
-
Al-Shraideh Y, Farooq U, Farney AC, Palanisamy A, Rogers J, Orlando G, Buckley MR, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ. Influence of recipient age on deceased donor kidney transplant outcomes in the expanded criteria donor era. Clin Transplant. 2014 Dec; 28(12):1372-82.
Score: 0.018
-
Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin. Expert Opin Biol Ther. 2014 Dec; 14(12):1723-30.
Score: 0.018
-
Sanders BP, Orlando G, Peloso A, Katari RS, Iskandar SS, Farney AC, Rogers J, Soker S, Stratta RJ. Osseus metaplasia in kidney allografts as a paradigm of regenerative medicine principles. Exp Clin Transplant. 2014 Aug; 12(4):371-3.
Score: 0.018
-
Farney AC, Rogers J, Orlando G, al-Geizawi S, Buckley M, Farooq U, al-Shraideh Y, Stratta RJ. Evolving experience using kidneys from deceased donors with terminal acute kidney injury. J Am Coll Surg. 2013 Apr; 216(4):645-55; discussion 655-6.
Score: 0.016
-
Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, Bonaccorsi-Riani E, Vanthuyne V, Hetsch N, Roggen F, Reyck CD, Goffette P, Latinne D, Orlando G, Rahier J, Sempoux C, Wallemacq P, Laterre PF, Gianello P. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Ann Surg. 2008 Dec; 248(6):956-67.
Score: 0.012